@ARTICLE{
author={Popovic Djordje S,Papachristou Stella,Papanas Nikolaos},
year={2025},
title={Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 Diabetes},
journal={CURRENT VASCULAR PHARMACOLOGY},
volume={},
number={},
pages={-},
document_type={Editorial Material; Early Access},
} 

@ARTICLE{
author={Papachristou Stella,Popovic Djordje S,Papanas Nikolaos},
year={2023},
title={Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk},
journal={INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES},
volume={43},
number={5},
pages={779-780},
document_type={Letter},
} 

@ARTICLE{
author={Popovic Djordje S,Papachristou Stella,Stokic Edita J,Papanas Nikolaos},
year={2022},
title={Ezetimibe and Insulin Resistance},
journal={CURRENT VASCULAR PHARMACOLOGY},
volume={20},
number={4},
pages={315-317},
document_type={Editorial Material},
} 

@ARTICLE{
author={Papachristou Stella,Popovic Djordje S,Papanas Nikolaos},
year={2022},
title={Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?},
journal={ADVANCES IN THERAPY},
volume={39},
number={6},
pages={2283-2286},
document_type={Editorial Material},
} 

@ARTICLE{
author={Papachristou Stella,Popovic Djordje S,Papanas Nikolaos},
year={2021},
title={The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?},
journal={DIABETES-METABOLISM RESEARCH AND REVIEWS},
volume={37},
number={8},
pages={-},
document_type={Editorial Material},
}